Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Drug Treatment Combined With Drug and Risk Reduction Counseling in the Prevention of HIV Infection and Death Among Injection Drug Users

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00270257
First received: December 22, 2005
Last updated: November 4, 2014
Last verified: November 2014